title: Cellular cardiomyoplasty: its past, present, and future.
abstract: Cellular cardiomyoplasty is a cell therapy using stem cells or progenitor cells for myocardial regeneration to improve cardiac function and mitigate heart failure. Since we first published cellular cardiomyoplasty in 1989, this procedure became the innovative method to treat damaged myocardium other than heart transplantation. A significant improvement in cardiac function, metabolism, and perfusion is generally observed in experimental and clinical studies, but the improvement is mild and incomplete. Although safety, feasibility, and efficacy have been well documented for the procedure, the beneficial mechanisms remain unclear and optimization of the procedure requires further study. This chapter briefly reviews the stem cells used for cellular cardiomyoplasty and their clinical outcomes with possible improvements in future studies.
authors.affiliation: Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
authors.forename: Elizabeth K
authors.initials: EK
authors.lastname: Lamb
authors.forename: Grace W
authors.initials: GW
authors.lastname: Kao
authors.forename: Race L
authors.initials: RL
authors.lastname: Kao
mesh_terms: D018421:Cardiomyoplasty / Q000379:methods*; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology*